​

Edesa Biotech Ownership | Who Owns Edesa Biotech?

OverviewRevenueFinancialsChart

Edesa Biotech Ownership Summary

Edesa Biotech is owned by 4.08% institutional investors, 15.04% insiders, and 80.88% retail investors. Velan capital investment management lp is the largest institutional shareholder, holding 10.38% of EDSA shares. Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund, with 0.97% of its assets in Edesa Biotech shares.

EDSA Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockEdesa Biotech4.08%15.04%80.88%
SectorHealthcare Stocks 35.58%11.87%52.55%
IndustryBiotech Stocks 35.75%11.83%52.41%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Velan capital investment management lp827.50K10.38%$4.33M
Rubric capital management lp687.50K8.62%$3.60M
Perceptive advisors563.24K7.06%$2.95M
Jane street group115.72K1.45%$605.22K
Geode capital management77.05K0.97%$403.02K
Vanguard group37.60K0.53%$54.52K
Vanguard fiduciary trust38.45K0.48%$201.07K
State street37.98K0.48%$198.63K
Commonwealth equity services35.00K0.44%$183.07K
Scientech research30.53K0.38%$159.69K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Velan capital investment management lp827.50K2.71%$4.33M
Scientech research30.53K0.13%$159.69K
Stonepine capital management30.00K0.06%$156.90K
Perceptive advisors563.24K0.06%$2.95M
Rubric capital management lp687.50K0.04%$3.60M
Virtu financial26.27K0.01%$137.00K
Schonfeld strategic advisors19.65K0.00%$102.77K
Sbi securities3.50K0.00%$18.32K
Scotia capital15.84K0.00%$82.86K
Commonwealth equity services35.00K0.00%$183.07K

Top Buyers

HolderShares% AssetsChange
Perceptive advisors563.24K0.06%563.24K
Velan capital investment management lp827.50K2.71%140.00K
Jane street group115.72K0.00%115.72K
Vanguard fiduciary trust38.45K0.00%38.45K
Commonwealth equity services35.00K0.00%35.00K

Top Sellers

HolderShares% AssetsChange
Stonepine capital management30.00K0.06%-657.50K
Nantahala capital management---625.00K
Drw securities---134.22K
Diadema partners lp---54.02K
Citadel advisors---53.63K

New Positions

HolderShares% AssetsChangeValue
Perceptive advisors563.24K0.06%563.24K$2.95M
Jane street group115.72K0.00%115.72K$605.22K
Vanguard fiduciary trust38.45K0.00%38.45K$201.07K
Scientech research30.53K0.13%30.53K$159.69K
Blackrock funding, inc. /de27.71K-27.71K$144.92K

Sold Out

HolderChange
Barclays-6.00
Raymond james financial-29.00
Fifth third bancorp-100.00
Morgan stanley-2.30K
Persistent asset partners-12.32K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202614-33.33%325,327-89.34%40.28%10---100.00%
Dec 31, 202515-34.78%2,928,4311.80%412.47%5-44.44%2-33.33%
Sep 30, 20252215.79%2,876,70836.46%402.59%1025.00%350.00%
Jun 30, 2025195.56%2,108,116-25.30%391.40%8-2-33.33%
Mar 31, 20251812.50%2,822,2061260.01%53138.22%833.33%350.00%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Institutional Extnd Mkt Idx Tr85.97K0.97%-
Fidelity Extended Market Index40.20K0.45%8.82K
Blackrock Extended Mkt Fund CF27.26K0.31%-
Extended Equity Market Fund K23.21K0.28%23.21K
BlackRock Extended Equity Market Fund K23.21K0.26%23.21K
Fidelity Total Market Index13.54K0.15%12.33K
DFA US Micro Cap I7.91K0.11%-
Fidelity Series Total Market Index9.60K0.11%4.37K
Spartan Extended Market Index Pool F9.53K0.11%4.49K
DFA US Core Equity 2 I3.42K0.10%-

Recent Insider Transactions

DateNameRoleActivityValue
Feb 26, 2026Brooks Michael J PresidentBuy$3.14K
Mar 05, 2026Nijhawan Pardeep Chief Executive OfficerBuy$39.00K
Mar 04, 2026Nijhawan Pardeep Chief Executive OfficerBuy$42.56K
Mar 03, 2026Nijhawan Pardeep Chief Executive OfficerBuy$36.30K
Mar 02, 2026Nijhawan Pardeep Chief Executive OfficerBuy$2.28K

Insider Transactions Trends

DateBuySell
2026 Q2--
2026 Q18-
2025 Q4--
2025 Q3--
2025 Q2--

EDSA Ownership FAQ

Who Owns Edesa Biotech?

Edesa Biotech shareholders are primarily institutional investors at 4.08%, followed by 15.04% insiders and 80.88% retail investors. The average institutional ownership in Edesa Biotech's industry, Biotech Stocks , is 35.75%, which Edesa Biotech falls below.

Who owns the most shares of Edesa Biotech?

Edesa Biotech’s largest shareholders are Velan capital investment management lp (827.5K shares, 10.38%), Rubric capital management lp (687.5K shares, 8.62%), and Perceptive advisors (563.24K shares, 7.06%). Together, they hold 26.07% of Edesa Biotech’s total shares outstanding.

Does Blackrock own Edesa Biotech?

BlackRock is not among the top 10 institutional shareholders of Edesa Biotech.

Who is Edesa Biotech’s biggest shareholder by percentage of total assets invested?

Velan capital investment management lp is Edesa Biotech’s biggest shareholder by percentage of total assets invested, with 2.71% of its assets in 827.5K Edesa Biotech shares, valued at 4.33M$.

Who is the top mutual fund holder of Edesa Biotech shares?

Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund holder of Edesa Biotech shares, with 0.97% of its total shares outstanding invested in 85.97K Edesa Biotech shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools